New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.
By Paul Winnington, Editorial Director
Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.
By Rossitza I. Chichkova, MD, MS and Lara Katzin, MD
By Julieanne P. Sees, DO and Joseph N. Daniel, DO
By Pau Winnington, Editorial Director.
Dementia Insights: OSA: Cognitive Consequences and Treatment of the Normal Population or those with AD
There’s clear evidence of a link between sleep disturbance and cognitive function. A specialist explores implications for patient management.
By Ronald Devere, MD
The newest formulation of botulinum toxin type A expands the treatment menu.
By Zac Haughn, Senior Associate Editor
Expert Opinion: In Search of the Cerebral Funny Bone: Brain Deficits and Their Neuropsychological Correlates with Humor
Trauma or other brain deficits can impact the patient’s ability to recognize and respond to humor.